GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Avicanna Inc (STU:0NN) » Definitions » Other Current Liabilities

Avicanna (STU:0NN) Other Current Liabilities : €0.19 Mil (As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is Avicanna Other Current Liabilities?

Avicanna's other current liabilities for the quarter that ended in Mar. 2025 was €0.19 Mil.

Avicanna's quarterly other current liabilities declined from Sep. 2024 (€0.71 Mil) to Dec. 2024 (€0.20 Mil) and declined from Dec. 2024 (€0.20 Mil) to Mar. 2025 (€0.19 Mil).

Avicanna's annual other current liabilities increased from Dec. 2022 (€0.00 Mil) to Dec. 2023 (€0.73 Mil) but then declined from Dec. 2023 (€0.73 Mil) to Dec. 2024 (€0.20 Mil).

Avicanna Other Current Liabilities Historical Data

The historical data trend for Avicanna's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avicanna Other Current Liabilities Chart

Avicanna Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only 0.09 - - 0.73 0.20

Avicanna Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.73 0.73 0.71 0.20 0.19

Avicanna Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Avicanna Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Avicanna's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Avicanna Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Avicanna Inc (STU:0NN) » Definitions » Other Current Liabilities
Comparable Companies
XCNQ:VEXT XCNQ:EPIC TSX:LABS TSXV:VM XCNQ:GWAY XCNQ:IAN XCNQ:CXXI TSXV:ROMJ XCNQ:OPTI NEOE:CBST ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
AVCNF:USA AVCN:Canada
Address
480 University Avenue, Suite 1502, Toronto, BC, CAN, M5G 1V2
Website
https://www.avicanna.com
Avicanna Inc is an innovative, commercial-stage, and international biopharmaceutical company focused on the development, advancement, and commercialization of evidence-based cannabinoid-based products for the global consumer, as well as medical and pharmaceutical market segments. In global cannabinoid advancements, it conducts most of its research in Canada at its research and development headquarters in JLABS in Toronto, located in the MaRS Discovery District. The company actively collaborates with Canadian academic and medical institutions. Avicanna has established a scientific platform including research and development and clinical development which led to the commercialization of more than twenty products across four main market segments.

Avicanna Headlines

No Headlines